Abstract
There is increasing evidence in some malignancies that the tumor clone is heterogeneous (phenotypically and functionally) in regard to proliferation and differentiation. The cancer stem cell hypothesis implies that not all the cells in the tumor have the same capacity to proliferate and maintain the growth of the tumor. Only a relative small fraction of cells in the tumor, termed cancer stem cells (CSCs), possess the ability to proliferate and self-renew extensively. In the past decade, several groups have reported the existence of a CSC population in different human brain tumors from both children and adults. Our study demonstrated the presence of a CSC population from a dog with glioblastoma multiforme (GBM) that possesses a great capacity for proliferation, self-renewal, and differentiation. This cell line is aneuploid, forms neurospheres in culture, possesses CSC markers, and reproduces the original dog GBM when inoculated into the nude mouse brain. A comparative approach to the study of canine glioblastoma CSC provides an excellent animal model for human glioblastoma pathogenesis and development of novel therapies in both species.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, Hjelmeland AB, Shi Q, McLendon RE, Bigner DD, Rich JN (2006) Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelia growth factor. Cancer Res 66:7843–7848
Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, Oefner PJ, Aigner L, Brawanski A, Bogdahn U, Beier CP (2007) CD133(+) and CD133(−) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67:4010–4015
Brat DJ, Castellano-Sanchez AA, Hunter SB, Pecot M, Cohen C, Hammond EH, Devi SN, Kaur B, Van Meir EG (2004) Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res 64:920–927
Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hammer B, Oh EY, Gaber MW, Finklestein D, Allen M, Frank A, Bayazitov IT, Zakharenko SS, Gajjar A, Davidoff A, Gilbertson RJ (2007) A perivascular niche for brain tumor stem cells. Cancer Cell 11:69–82
Clarke MF, Fuller M (2006) Stem cells and cancer: two faces of eve. Cell 124:1111–1115
Dickinson PJ, LeCouteur RA, Higgins RJ, Bringas JR, Larson RF, Yamashita Y, Krauze MT, Forsayeth J, Noble CO, Drummond DC, Kirpotin DB, Park JW, Berger MS, Bankiewicz KS (2010) Canine spontaneous glioma: a translational model system for convection-enhanced delivery. Neuro Oncol 12(9):928–940
Dirks PB (2008) Brain tumour stem cells: the undercurrents of human brain cancer and their relationship to neural stem cells. Philos Trans R Soc Lond B Biol Sci 363:139–152
Dong S, Nutt CL, Betensky RA, Stemmer-Rachamimov AO, Denko NC, Ligon KL, Rowitch DH, Louis DN (2005) Histology-based expression profiling yields novel prognostic markers in human glioblastoma. J Neuropathol Exp Neurol 64:948–955
Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA (1995) Definition of two angiogenic pathways by distinct αv integrins. Science 270:1500–1502
Fuchs E, Tumbar T, Guasch G (2004) Socializing with the neighbors: stem cells and their niche. Cell 116:769–778
Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F, Vescovi A (2004) Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64:7011–7021
Gavin PR, Fike JR, Hoopes JP (1995) Central nervous system tumors. Semin Vet Med Surg (Small Anim) 10:180–189
Günther HS, Schmidt N, Phillips HS, Kemming D, Kharbanda S, Soraino R, Modrusan Z, Meissner H, Westphal M, Lamszus K (2008) Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene 27:2897–2909
Heidner GL, Kornegay JN, Page LR, Dodge RK, Thrall DE (1991) Analysis of survival in a retrospective study of 86 dogs with brain tumors. J Vet Intern Med 5:219–226
Kleihues P, Cavenee WK (2000) World Health Organization classification of tumours of the nervous system. WHO/IARC, Lyon
Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, Park JK, Fine HA (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9:391–403
Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, Lu L, Irvin D, Black KL, Yu JS (2006) Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 5:67
Louis DN (2006) Molecular pathology of malignant gliomas. Annu Rev Pathol 1:97–117
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2006) World Health Organization classification of tumours of the central nervous system. WHO/IARC, Lyon
Lungu GF, Li ML, Xie X, Wang LV, Stoica G (2007) In vivo imaging and characterization of hypoxia-induced neovascularization and tumor invasion. Int J Oncol 30:45–54
Mizejewski GJ (1999) Role of integrins in cancer: survey of expression patterns. Proc Soc Exp Biol Med 222(2):124–138
Paulus W, Baur I, Beutler AS, Reeves SA (1996) Diffuse brain invasion of glioma cells requires β1 integrins. Lab Invest 75:819–826
Pierret C, Spears K, Morrison JA, Maruniak JA, Katz ML, Kirk MD (2007) Elements of neural stem cell niche derived from embryonic stem cells. Stem Cells Dev 16:1017–1026
Pilkington GJ (2005) Cancer stem cells in the mammalian central nervous system. Cell Prolif 38:423–433
Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkleman RM, Cusimano MD, Dirks PB (2004) Identification of human brain tumour initiating cells. Nature 432:396–401
Stoica G, Kim HT, Hall DG, Coates JR (2004) Morphology, immunohistochemistry, and genetic alterations in dog astrocytomas. Vet Pathol 41:10–19
Stoica G, Lungu G, Martini-Stoica H, Waghela S, Levine J, Smith R III (2009) Identification of cancer stem cells in dog glioblastoma. Vet Pathol 46:391–406
Stoica G, Levine J, Wolff J, Murphy K (2011 Jan) Canine astrocytic tumors: a comparative review. Vet Pathol 48(1):266–275
Summers BA, Cummings JF, de Lahunta A (1995) Tumors of the central nervous system. In Veterinary neuropathology. Mosby, St. Louis, MO, pp 351–401
Suzuma K, Takagi H, Otani A, Honda Y (1998) Hypoxia and vascular endothelial growth factor stimulate angiogenic integrin expression in bovine retinal microvascular endothelial cells. Invest Ophthalmol Vis Sci 39:1028–1035
Thomas WB, Wheeler SJ, Kramer R, Kornegay JN (1996) Magnetic resonance imaging features of primary brain tumors in dogs. Vet Radiol Ultrasound 37:20–27
Turrel JM, Fike JR, LeCouteur RA, Higgins RJ (1986) Computed tomographic characteristics of primary brain tumors in 50 dogs. JAVMA 188:851–856
Vaupel P (2004) The role of hypoxia-induced factors in tumor progression. Oncologist 9:25
Vescovi AL, Galli R, Reynolds BA (2006) Brain tumour stem cells. Nat Rev Cancer 6:425–436
Ward RJ, Dirks PB (2007) Cancer stem cells: at the headwaters of tumor development. Annu Rev Pathol 2:175–189
Acknowledgments
This work was supported in part by a grant from Canine Health Foundation (Acorn), USA.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Stoica, G., Lungu, G. (2013). Isolation and Characterization of Cancer Stem Cells from Dog Glioblastoma. In: Hayat, M. (eds) Stem Cells and Cancer Stem Cells, Volume 10. Stem Cells and Cancer Stem Cells, vol 10. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6262-6_20
Download citation
DOI: https://doi.org/10.1007/978-94-007-6262-6_20
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6261-9
Online ISBN: 978-94-007-6262-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)